Millions of adults in their 20s or older have coronary artery disease. But experts say the common condition doesn’t have to be an inevitable part of aging. There are steps you can take to reduce your ...

The high school student is already giving presentations around the world for his work on AI’s impact on health care.

Florida driver was going 135 mph in fatal crash that split car in half, cops say Biden warns of dark days for the country as he urges Americans to stay optimistic Singles are paying $200 to hold each ...

Faulty versions of the LMNA gene can cause a wide range of health problems, including heart muscle disease (dilated cardiomyopathy) and muscle weakness (muscular dystrophies). Many of these diseases ...

Share on Pinterest A new study found that GLP1-RA medications may help lower the risk of a cardiovascular event in people with type 2 diabetes. Getty Images Researchers say GLP-1 drugs prescribed for ...

Study: MRI-based multi-organ clocks for healthy aging and disease assessment. Image Credit: VesnaArt / Shutterstock In a recent study published in the journal Nature Medicine, researchers developed ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Global mortality rates are falling, but not among youths and young adults, according to the latest Global Burden of Disease (GBD) study published in The Lancet today and presented at the World Health ...

Traditional healers have used ginger to treat common ailments for centuries. Now current research has documented many of ginger’s benefits, as well as its side effects. You might feel motivated to ...

An Nvidia NVDA-3.96%decrease; red down pointing triangle-backed AI startup is planning to build a massive data-center complex with CoreWeave CRWV-8.37%decrease; red down pointing triangle that is ...

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk’s Rare Disease portfolio Omeros is eligible to receive 340 million US dollars in ...